{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:14:11Z","timestamp":1784139251716,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25461165"],"award-info":[{"award-number":["JP25461165"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.cellimm.2022.104652","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T10:52:46Z","timestamp":1669805566000},"page":"104652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Diverse and divergent functions of IL-32\u03b2 and IL-32\u03b3 isoforms in the regulation of malignant pleural mesothelioma cell growth and the production of VEGF-A and CXCL8"],"prefix":"10.1016","volume":"383","author":[{"given":"Muneo","family":"Numasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koyu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Notsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Tomioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Unno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellimm.2022.104652_b0005","first-page":"131","article-title":"Interleukin-32: a cytokine and inducer of TNFalpha","volume":"22","author":"Kim","year":"2005","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.cellimm.2022.104652_b0010","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1074\/jbc.M111.288290","article-title":"Interleukin 32 (IL-32) contains a typical alpha-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1","volume":"287","author":"Heinhuis","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104652_b0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/intimm\/dxh339","article-title":"Involvement of IL-32 in activation-induced cell death in T cells","volume":"18","author":"Goda","year":"2006","journal-title":"Int. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2022.104652_b0020","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar2074","article-title":"Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases","volume":"8","author":"Shoda","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.cellimm.2022.104652_b0025","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1371\/journal.pmed.0030277","article-title":"Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1\/IL-18\/interferon-gamma-dependent mechanism","volume":"3","author":"Netea","year":"2006","journal-title":"PLoS Med."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104652_b0030","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.ijrobp.2009.04.017","article-title":"Interleukin-32 positively regulates radiation-induced vascular inflammation","volume":"74","author":"Kobayashi","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.cellimm.2022.104652_b0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.biochi.2014.01.013","article-title":"Interaction network mapping among IL-32 isoforms","volume":"101","author":"Kang","year":"2014","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.cellimm.2022.104652_b0040","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2567.2008.02917.x","article-title":"Identification of the most active interleukin-32 isoform","volume":"126","author":"Choi","year":"2009","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.cellimm.2022.104652_b0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cyto.2012.07.010","article-title":"Interleukin-32: a predominantly intracellular proinflammatory mediator that controls cell activation and cell death","volume":"60","author":"Heinhuis","year":"2012","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.cellimm.2022.104652_b0050","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1073\/pnas.0511206103","article-title":"Proteinase 3 is an IL-32 binding protein","volume":"103","author":"Novick","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellimm.2022.104652_b0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2019.01.012","article-title":"Multiple myeloma cell-derived IL-32gamma increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expression","volume":"446","author":"Yan","year":"2019","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104652_b0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4049\/jimmunol.1202802","article-title":"IL-32 promotes angiogenesis","volume":"192","author":"Nold-Petry","year":"2014","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104652_b0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cyto.2012.09.022","article-title":"Expression of IL-32 modulates NF-kappa B and p38 MAP kinase pathways in human esophageal cancer","volume":"61","author":"Yousif","year":"2013","journal-title":"Cytokine"},{"issue":"30","key":"10.1016\/j.cellimm.2022.104652_b0070","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/onc.2011.52","article-title":"IL-32gamma inhibits cancer cell growth through inactivation of NF-kappaB and STAT3 signals","volume":"30","author":"Oh","year":"2011","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.cellimm.2022.104652_b0075","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2018.09.009","article-title":"High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice","volume":"49","author":"Crinier","year":"2018","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cellimm.2022.104652_b0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cyto.2009.10.003","article-title":"Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFalpha and IL-1beta","volume":"49","author":"Hong","year":"2010","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.cellimm.2022.104652_b0085","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1073\/pnas.0511233103","article-title":"IL-32, a proinflammatory cytokine in rheumatoid arthritis","volume":"103","author":"Joosten","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.cellimm.2022.104652_b0090","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1073\/pnas.0712381105","article-title":"Interleukin 32 induces the differentiation of monocytes into macrophage-like cells","volume":"105","author":"Netea","year":"2008","journal-title":"Proc. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104652_b0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3892\/ol.2014.2641","article-title":"IL-32 promotes breast cancer cell growth and invasiveness","volume":"9","author":"Wang","year":"2015","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104652_b0100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/oby.21001","article-title":"Interleukin-32\u03b2 ameliorates metabolic disorder and liver damage in mice fed high-fat diet","volume":"23","author":"Lee","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.cellimm.2022.104652_b0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2018.02.027","article-title":"Interleukin-32 upregulates the expression of ABCA1 and ABCG1 resulting in reduced intracellular lipid concentrations in primary human hepatocytes","volume":"271","author":"Damen","year":"2018","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.cellimm.2022.104652_b0110","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.2650","article-title":"NOD2 trigers an interleukin-32-dependent human dendritic cell program in leprosy","volume":"18","author":"Schenk","year":"2012","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104652_b0115","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jaci.2010.01.016","article-title":"IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis","volume":"125","author":"Meyer","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104652_b0120","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1073\/pnas.1016005108","article-title":"Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis","volume":"108","author":"Heinhuis","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"29","key":"10.1016\/j.cellimm.2022.104652_b0125","doi-asserted-by":"crossref","first-page":"20927","DOI":"10.1074\/jbc.M112.440115","article-title":"Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon lambda1 (IFN-lambda1)","volume":"288","author":"Li","year":"2013","journal-title":"J. Biol. Chem."},{"key":"#cr-split#-10.1016\/j.cellimm.2022.104652_b0130.1","doi-asserted-by":"crossref","unstructured":"X. Bai, S.H. Kim, T. Azam, M.T. McGibney, H. Huang, C.A. Dinarello, E.D. Chan, IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages. J. Immunol. 2010 184","DOI":"10.4049\/jimmunol.0901913"},{"key":"#cr-split#-10.1016\/j.cellimm.2022.104652_b0130.2","doi-asserted-by":"crossref","unstructured":"(7) (2010) 3830-3840, https:\/\/doi.org\/10.4049\/jimmunol.0901913.","DOI":"10.4049\/jimmunol.0901913"},{"key":"10.1016\/j.cellimm.2022.104652_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.837590","article-title":"A Paradoxical Effect of Interleukin-32 Isoforms on Cancer","volume":"13","author":"Shim","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104652_b0140","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.canlet.2011.12.023","article-title":"Dysregulation of overexpressed IL-32\u03b1 in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-\u03baB and Bcl-2","volume":"318","author":"Kang","year":"2012","journal-title":"Cancer Lett."},{"issue":"26","key":"10.1016\/j.cellimm.2022.104652_b0145","doi-asserted-by":"crossref","first-page":"17868","DOI":"10.1074\/jbc.M900368200","article-title":"Interleukin-32 expression in the pancreas","volume":"284","author":"Nishida","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2022.104652_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.704853","article-title":"Interleukin 32 Promotes Foxp3+ Treg Cell Development and CD8+ T Cell Function in Human Esophageal Squamous Cell Carcinoma Microenvironment","volume":"9","author":"Han","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.cellimm.2022.104652_b0155","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1158\/1078-0432.CCR-13-1221","article-title":"Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis","volume":"20","author":"Tsai","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.cellimm.2022.104652_b0160","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.200903-0400OC","article-title":"Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype","volume":"180","author":"Sorrentino","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104652_b0165","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/carcin\/bgv172","article-title":"Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines","volume":"37","author":"Heinhuis","year":"2016","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.cellimm.2022.104652_b0170","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41419-018-0375-6","article-title":"IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation","volume":"9","author":"Yun","year":"2018","journal-title":"Cell Death Dis."},{"issue":"18","key":"10.1016\/j.cellimm.2022.104652_b0175","doi-asserted-by":"crossref","first-page":"e138772","DOI":"10.1172\/jci.insight.138772","article-title":"IL-32\u03b3 potentiates tumor immunity in melanoma","volume":"5","author":"Gruber","year":"2020","journal-title":"JCI Insight."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104652_b0180","first-page":"4655","article-title":"IL-32 expression indicates unfavorable prognosis in patients with colon cancer","volume":"17","author":"Zhai","year":"2019","journal-title":"Oncol. Lett."},{"issue":"54","key":"10.1016\/j.cellimm.2022.104652_b0185","doi-asserted-by":"crossref","first-page":"92841","DOI":"10.18632\/oncotarget.21611","article-title":"Interleukin-32alpha promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.cellimm.2022.104652_b0190","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","article-title":"Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor","volume":"3","author":"Yao","year":"1995","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.cellimm.2022.104652_b0195","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2022.104652_b0200","doi-asserted-by":"crossref","unstructured":"F. Fossiez, O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J.J. Pin, P. Garrone, E. Garcia, S. Saeland, D. Blanchard, C. Gaillard, B. Das Mahapatra, E. Rouvier, P. Golstein, J. Banchereau, S. Lebecque, T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183(6) (1996) 2593-2603, https:\/\/doi.org\/10.1084\/jem.183.6.2593.","DOI":"10.1084\/jem.183.6.2593"},{"key":"10.1016\/j.cellimm.2022.104652_b0205","doi-asserted-by":"crossref","unstructured":"M. Numasaki, J. Fukushi, M. Ono, S.K. Narula, P.J. Zavodny, T. Kudo, P.D. Robbins, H. Tahara , M.T. Lotze, Interleukin-17 promotes angiogenesis and tumor growth. Blood 101(7) (2003) 2620-2627, https:\/\/doi.org\/ 10.1182\/blood-2002-05-1461.","DOI":"10.1182\/blood-2002-05-1461"},{"key":"10.1016\/j.cellimm.2022.104652_b0210","doi-asserted-by":"crossref","unstructured":"P. Miossec P, J.K. Kolls, Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11(10) (2012) 763-776, https:\/\/doi.org\/10.1038\/nrd3794.","DOI":"10.1038\/nrd3794"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104652_b0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/imr.12183","article-title":"Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense","volume":"260","author":"McAleer","year":"2014","journal-title":"Immunol Rev."},{"key":"10.1016\/j.cellimm.2022.104652_b0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cellimm.2017.10.015","article-title":"The paradox of Th17 cell functions in tumor immunity","volume":"322","author":"Asadzadeh","year":"2017","journal-title":"Cell. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104652_b0225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4110\/in.2014.14.3.123","article-title":"Interleukin-32 in inflammatory autoimmune diseases","volume":"14","author":"Kim","year":"2014","journal-title":"Immune Netw."},{"issue":"6","key":"10.1016\/j.cellimm.2022.104652_b0230","doi-asserted-by":"crossref","first-page":"R246","DOI":"10.1186\/ar4089","article-title":"IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis","volume":"14","author":"Moon","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104652_b0235","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.4049\/jimmunol.1002306","article-title":"Inflammatory cytokines IL-32 and IL-17 have common signaling intermediates despite differential dependence on TNF-receptor 1","volume":"186","author":"Turner-Brannen","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2022.104652_b0240","doi-asserted-by":"crossref","unstructured":"E. Moreira Gabriel, T.R. Wiche Salinas, A. Gosselin, E. Larouche-Anctil, M. Durand, A.L. Landay, M. El-Far, C.L. Tremblay, J.P. Routy, P. Ancuta, Overt IL-32 isoform expression at intestinal level during HIV-1 infection is negatively regulated by IL-17A. AIDS 35(12) (2021) 1881-1894, https:\/\/doi.org\/10.1097\/ QAD.0000000000002972.","DOI":"10.1097\/QAD.0000000000002972"},{"key":"10.1016\/j.cellimm.2022.104652_b0245","doi-asserted-by":"crossref","unstructured":"Z.H. Nemeth, D.A. Bogdanovski, P. Barratt-Stopper, S.R. Paglinco, L. Antonioli, R.H. Rolandelli, Crohn's Disease and Ulcerative Colitis Show Unique Cytokine Profiles. Cureus 9(4) (2017) e1177, https:\/\/doi.org\/ 10.7759\/cureus.1177.","DOI":"10.7759\/cureus.1177"},{"issue":"3","key":"10.1016\/j.cellimm.2022.104652_b0250","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1634\/theoncologist.2008-0232","article-title":"The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies","volume":"14","author":"Scagliotti","year":"2009","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.cellimm.2022.104652_b0255","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/107327480801500205","article-title":"Molecular analysis-based treatment strategies for non-small cell lung cancer","volume":"15","author":"Bepler","year":"2008","journal-title":"Cancer Control"},{"issue":"6423","key":"10.1016\/j.cellimm.2022.104652_b0260","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/362841a0","article-title":"Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo","volume":"362","author":"Kim","year":"1993","journal-title":"Nature"},{"issue":"5089","key":"10.1016\/j.cellimm.2022.104652_b0265","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1126\/science.1281554","article-title":"Interleukin-8 as a macrophage-derived mediator of angiogenesis","volume":"258","author":"Koch","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2022.104652_b0270","doi-asserted-by":"crossref","first-page":"21S","DOI":"10.1378\/chest.109.3_Supplement.21S","article-title":"Angiogenesis in mesotheliomas. Role of mesothelial cell derived IL-8","author":"Antony","year":"1996","journal-title":"Chest 109(3 Suppl)"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104652_b0275","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.bjc.6690650","article-title":"VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours","volume":"81","author":"Ohta","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cellimm.2022.104652_b0280","doi-asserted-by":"crossref","unstructured":"H. Fujie, T. Tanaka M. Tagawa, N. Kaijun, M. Watanabe, T. Suzuki, K. Nakayama, M. Numasaki, Antitumor activity of type III interferon alone or in combination with type I interferon against human non-small cell lung cancer. Cancer Sci. 102(11) (2011) 1977-1990, https:\/\/doi.org\/10.1111\/j.1349-7006.2011.02079.x.","DOI":"10.1111\/j.1349-7006.2011.02079.x"},{"key":"10.1016\/j.cellimm.2022.104652_b0285","doi-asserted-by":"crossref","unstructured":"K. Hasegawa, M. Tagawa, K. Takagi, H. Tsukamoto, Y. Tomioka, T. Suzuki, Y. Nishioka, T. Ohrui, M. Numasaki, Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A\/IFN-\u03bb2 or IL-29\/IFN-\u03bb1. Cancer Gene Ther. 23(8) (2016) 266-277, https:\/\/doi.org\/ 10.1038\/cgt.2016.29.","DOI":"10.1038\/cgt.2016.29"},{"issue":"2","key":"10.1016\/j.cellimm.2022.104652_b0290","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbrc.2011.03.021","article-title":"IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma","volume":"407","author":"Liu","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellimm.2022.104652_b0295","doi-asserted-by":"crossref","unstructured":"S. Amara S, D. Alotaibi, V. Tiriveedhi, NFAT5\/STAT3 interaction mediates synergism of high salt with IL-17 towards induction of VEGF-A expression in breast cancer cells. Oncol. Lett. 12(2) (2016) 933-943, https:\/\/doi.org\/10.3892\/ol.2016.4713.","DOI":"10.3892\/ol.2016.4713"},{"issue":"5","key":"10.1016\/j.cellimm.2022.104652_b0300","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/07357907.2014.898156","article-title":"Interleukin-8 and interleukin-17 for cancer","volume":"32","author":"Zarogoulidis","year":"2014","journal-title":"Cancer Invest."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104652_b0305","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s10753-011-9419-0","article-title":"A distinct regulatory role of Th17 cytokines IL-17A and IL-17F in chemokine secretion from lung microvascular endothelial cells","volume":"35","author":"Fujie","year":"2012","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104652_b0310","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1620\/tjem.240.47","article-title":"A Heterodimeric Cytokine, Consisting of IL-17A and IL-17F, Promotes Migration and Capillary-Like Tube Formation of Human Vascular Endothelial Cells","volume":"240","author":"Numasaki","year":"2016","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.cellimm.2022.104652_b0315","unstructured":"M. Numasaki, K. Ito, VEGF-A, HGF and bFGF are Involved in IL-17A-mediated Migration and Capillary-like Vessel Formation of Vascular Endothelial Cells. Iran. J. Immunol. 18(2) (2021) 103-110, https:\/\/doi.org\/ 10.22034\/iji.2021.91214.2059."},{"key":"10.1016\/j.cellimm.2022.104652_b0320","doi-asserted-by":"crossref","unstructured":"J. Lee, K.E. Kim, S. Cheon, J.H. Song, Y. Houh, T.S. Kim, M. Gil, K.J. Lee, S. Kim, D. Kim, D.Y. Hur, Y. Yang, S.I. Bang, H.J. Park, D. Cho, Interleukin-32\u03b1 induces migration of human melanoma cells through downregulation of E-cadherin. Oncotarget 7(40) (2016) 65825-65836, https:\/\/doi.org\/10.18632\/oncotarget. 11669.","DOI":"10.18632\/oncotarget.11669"},{"issue":"3","key":"10.1016\/j.cellimm.2022.104652_b0325","first-page":"1155","article-title":"Overexpression of interleukin-32\u03b1 promotes invasion by modulating VEGF in hepatocellular carcinoma","volume":"39","author":"Zhao","year":"2018","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.cellimm.2022.104652_b0330","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s13402-013-0154-4","article-title":"Interleukin-32\u03b2 stimulates migration of MDA-MB-231 and MCF-7 cells via the VEGF-STAT3 signaling pathway","volume":"36","author":"Park","year":"2013","journal-title":"Cell Oncol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104652_b0335","first-page":"41","article-title":"Role of interleukin-32 in cancer biology","volume":"16","author":"Yan","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cellimm.2022.104652_b0340","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.smim.2018.03.004","article-title":"Insights into the role of IL-32 in cancer","volume":"38","author":"Sloot","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.cellimm.2022.104652_b0345","doi-asserted-by":"crossref","unstructured":"H. Suga, M. Sugaya, T. Miyagaki, M. Kawaguchi, H. Fujita, Y. Asano, Y. Tada, T. Kadono, S. Sato, The role of IL-32 in cutaneous T-cell lymphoma. J. Invest. Dermatol. 134(5) (2014) 1428-1435, https:\/\/doi.org\/ 10.1038\/jid.2013.488.","DOI":"10.1038\/jid.2013.488"},{"issue":"4","key":"10.1016\/j.cellimm.2022.104652_b0350","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jaci.2011.12.1002","article-title":"Inhibition of angiogenesis by IL-32: possible role in asthma","volume":"129","author":"Meyer","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2022.104652_b0355","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.4049\/jimmunol.175.9.6177","article-title":"IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis","volume":"175","author":"Numasaki","year":"2005","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2022.104652_b0360","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41419-019-1737-4","article-title":"IL-32gamma suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated STAT5 pathway","volume":"10","author":"Lee","year":"2019","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.cellimm.2022.104652_b0365","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1038\/sj.ki.5001948","article-title":"IL-1beta induces VEGF, independently of PGE2 induction, mainly through the PI3-K\/mTOR pathway in renal mesangial cells","volume":"70","author":"Sol\u00e0-Vill\u00e0","year":"2006","journal-title":"Kidney Int."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874922001770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874922001770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:10:02Z","timestamp":1757805002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874922001770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":74,"alternative-id":["S0008874922001770"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2022.104652","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diverse and divergent functions of IL-32\u03b2 and IL-32\u03b3 isoforms in the regulation of malignant pleural mesothelioma cell growth and the production of VEGF-A and CXCL8","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2022.104652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104652"}}